Ginestier et al. [44] reported that high expression of ALDH1A1 mRNA was correlated with poorer overall survival in breast cancer patients, and as a result, ALDH1A1 was the only ALDH1 isozyme capable of serving as a biomarker for predicting poor survival in breast cancer patients [93]. Here, ALDH1A1 is linked to breast carcinoma.